DE60130565D1 - Pde8a und seine verwendung - Google Patents

Pde8a und seine verwendung

Info

Publication number
DE60130565D1
DE60130565D1 DE60130565T DE60130565T DE60130565D1 DE 60130565 D1 DE60130565 D1 DE 60130565D1 DE 60130565 T DE60130565 T DE 60130565T DE 60130565 T DE60130565 T DE 60130565T DE 60130565 D1 DE60130565 D1 DE 60130565D1
Authority
DE
Germany
Prior art keywords
nucleic acid
acid molecules
novel pde
proteins
pna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60130565T
Other languages
English (en)
Inventor
A Joseph
Seebeck Thomas
Haydn Soderling Scott
Rascon Ana
Zoraghi Roya
Kunz Stefan
Gong Kewei
Glavas Natalie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Bern
University of Washington
Original Assignee
Universitaet Bern
University of Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Bern, University of Washington filed Critical Universitaet Bern
Application granted granted Critical
Publication of DE60130565D1 publication Critical patent/DE60130565D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
DE60130565T 2000-09-12 2001-09-12 Pde8a und seine verwendung Expired - Lifetime DE60130565D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23244500P 2000-09-12 2000-09-12
US24050000P 2000-10-12 2000-10-12
PCT/US2001/028503 WO2002022661A2 (en) 2000-09-12 2001-09-12 NOVEL PDEs AND USES THEREOF

Publications (1)

Publication Number Publication Date
DE60130565D1 true DE60130565D1 (de) 2007-10-31

Family

ID=26925998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60130565T Expired - Lifetime DE60130565D1 (de) 2000-09-12 2001-09-12 Pde8a und seine verwendung

Country Status (6)

Country Link
US (2) US7138259B2 (de)
EP (1) EP1317553B1 (de)
AT (1) ATE373717T1 (de)
AU (1) AU2001289034A1 (de)
DE (1) DE60130565D1 (de)
WO (1) WO2002022661A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE373717T1 (de) * 2000-09-12 2007-10-15 Univ Washington Pde8a und seine verwendung
EP1439221B1 (de) * 2002-12-17 2007-01-24 F. Hoffmann-La Roche Ag PDE Kern Konstrukt
WO2005023856A2 (en) * 2003-09-05 2005-03-17 University Of Bern Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
BRPI0414886A (pt) 2003-09-29 2006-12-12 Topigen Pharma Inc composições de oligonucleotìdeo e métodos para o tratamento de doença incluindo condições inflamatórias
US20090105281A1 (en) * 2006-04-27 2009-04-23 Paul Epstein Methods of treating inflammation
CA2652539A1 (en) 2006-05-19 2007-11-29 Topigen Pharmaceuticals Inc. Oligonucleotides affecting expression of phosphodiesterases
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
JP2024500919A (ja) * 2020-12-23 2024-01-10 ジェンザイム・コーポレーション 重水素化コロニー刺激因子－１受容体（ｃｓｆ－１ｒ）阻害剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
DE3513168A1 (de) 1985-04-12 1986-10-16 Thomas 8000 München Dandekar Biosensor bestehend aus einem halbleiter auf silizium oder kohlenstoffbasis (elektronischer teil) und nukleinbasen (od. anderen biol. monomeren)
US5194428A (en) 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5110802A (en) 1987-07-14 1992-05-05 City Of Hope Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates
US5080548A (en) * 1990-07-05 1992-01-14 Columbia Trailer Co., Inc. Trailer dumper
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US6080548A (en) * 1997-11-19 2000-06-27 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterases
US5798246A (en) * 1996-03-25 1998-08-25 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase
US5932465A (en) * 1997-10-16 1999-08-03 Icos Corporation Phosphodiesterase 8A
US5922595A (en) * 1997-12-09 1999-07-13 Incyte Pharmaceuticals, Inc. Cyclic GMP phosphodiesterase
US6686196B2 (en) * 2000-05-03 2004-02-03 University Of Washington Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereof
ATE373717T1 (de) * 2000-09-12 2007-10-15 Univ Washington Pde8a und seine verwendung

Also Published As

Publication number Publication date
US20050058998A1 (en) 2005-03-17
WO2002022661A2 (en) 2002-03-21
WO2002022661A3 (en) 2003-03-13
ATE373717T1 (de) 2007-10-15
EP1317553B1 (de) 2007-09-19
AU2001289034A1 (en) 2002-03-26
US20070116705A1 (en) 2007-05-24
EP1317553A2 (de) 2003-06-11
US7138259B2 (en) 2006-11-21
US7598067B2 (en) 2009-10-06

Similar Documents

Publication Publication Date Title
ATE530911T1 (de) Bindungsproteine als biosensoren
ATE402188T1 (de) Bindungsproteine als biosensoren
CA2395724A1 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES
WO1997035989A3 (en) Cyclic nucleotide phosphodiesterase
DE60130565D1 (de) Pde8a und seine verwendung
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
Bürger et al. Fibronectin synthesis by human tubular epithelial cells in culture: effects of PDGF and TGF-β on synthesis and splicing
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
HK1088016A1 (en) Isolated fluorescent protein from clytia gregaria cgfp and use thereof
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
WO2002026930A3 (en) Nucleic acids, proteins, and antibodies
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
ATE291621T1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
DE69943374D1 (de) Verfahren zur modulation der angiogenese mittels der tyrosin kinase src
EP1265073A3 (de) Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
ATE421698T1 (de) Intrinsic-faktor vom schwein
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
DE60336265D1 (de) Inhibitoren der enzymaktivität der endooligopeptidase a (eopa) und ihre verwendungen
DE60333747D1 (de) Dna-enzym zur hemmung von plasminogenaktivator-inhibitor-1
WO2003044170A3 (en) Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen
ATE384804T1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND ZUR DETEKTION VON PROLIFERATIVEN STÖRUNGEN DIE MIT DER ÜBEREXPRESSION DES MENSCHLICHEN ßTRANSKETOLASE LIKE-1ß GENS IN ZUSAMMENHANG STEHEN
EP1711604A4 (de) Diabetogene epitope

Legal Events

Date Code Title Description
8332 No legal effect for de